GlassScriptPhysician profile
Sonya S Wakil
NPI 1386832004
$2,071.50
in general payments reported to CMS, 2019-2025
21 companies · $450 in 2025
The $450 reported for 2025 was more than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $923 · 2020: $156 · 2021: $57.19 · 2022: $60.79 · 2023: $251 · 2024: $173 · 2025: $450.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $874.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $874.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Corium, LLC | $333.83 | 2022-2025 | Azstarys |
| Neurocrine Biosciences, INC. | $317.54 | 2019-2020 | |
| Allergan, INC. | $237.86 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $132.46 | 2019-2025 | Trintellix |
| Supernus Pharmaceuticals, INC. | $129.75 | 2021-2025 | Qelbree, Qelbree |
| Axsome Therapeutics, INC. | $115.11 | 2025 | Auvelity |
| Vertical Pharmaceuticals, LLC | $102.70 | 2019-2025 | Relexxii |
| Otsuka America Pharmaceutical, INC. | $95.86 | 2019-2025 | Rexulti |
| Tris Pharma INC | $93.51 | 2019-2025 | Dyanavel Xr |
| Sunovion Pharmaceuticals INC. | $90.41 | 2019-2021 | |
| Abbvie INC. | $70.69 | 2025 | |
| Shire North American Group INC | $70.29 | 2019 | |
| Janssen Pharmaceuticals, INC | $66.30 | 2019-2020 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $40.24 | 2023-2024 | Caplyta |
| Lundbeck LLC | $36.49 | 2019-2020 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Neos Therapeutics, LP | $34.79 | 2020 | |
| Ironshore Pharmaceuticals INC. | $29.03 | 2023 | Jornay Pm |
| Owp Pharmaceuticals, INC. | $21.66 | 2019 | |
| Alkermes, INC. | $18.87 | 2024 | Aristada, Lybalvi |
| Eisai INC. | $18.40 | 2020 | |
| Collegium Pharmaceutical, INC. | $15.71 | 2025 | Jornay Pm |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sonya Wakil listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.